ArticleFrontiers in oncology2022

Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade.

Jean-Michel Lavoie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.